Initiation of Insulin Aspart in Type 2 Diabetes

Evaluation of the Initiation of Insulin Treatment Using Insulin Aspart on Blood Glucose Profile in Type 2 Diabetes Mellitus

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00572806

Enrollment

Registered

2007-12-13

Start date

2003-02-05

Completion date

2004-02-02

Last updated

2017-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetes Mellitus, Type 2

Brief summary

This trial is conducted in Europe. The aim of this trial is to investigate if using insulin aspart as start therapy will improve the efficacy on daytime blood glucose cycle profile in subjects with type 2 diabetes.

Interventions

DRUGinsulin aspart

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

30 Years to No maximum

Healthy volunteers

Inclusion criteria

* Type 2 diabetes for at least 3 years * HbA1c greater than 8.0% * Body Mass Index (BMI) below 40.0 kg/m2 * Inadequate treatment with diet and OADs * Never received treatment with insulin

Exclusion criteria

* Type 1 diabetes * Known or suspected allergy to investigational product

Design outcomes

Primary

Measure	Time frame
Blood glucose value	at 5 pm in a daytime blood glucose cycle profile

Secondary

Measure	Time frame
Evaluation of 24-hour blood glucose cycle	—
HbA1c	—
Hypoglycaemic episodes	—

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026